John Diekman

Founding Partner at 5AM Venture Management LLC

John Diekman

John Diekman

Founding Partner at 5AM Venture Management LLC

Overview
Career Highlights

Affymax NV
Salutar, Inc.
Monoclonal Antibodies Inc.

RelSci Relationships

2036

Number of Boards

31

Birthday

1944

Age

76

Number of Awards

2

Relationships
RelSci Relationships are individuals John Diekman likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Executive Officer at The Scripps Research Institute

Relationship likelihood: Strong

Founder at Cleave Therapeutics, Inc.

Relationship likelihood: Strong

Founder at 5AM Venture Management LLC

Relationship likelihood: Strong

Co-Founder at Indiana Proteomics Consortium LLC

Relationship likelihood: Strong

Founding Partner at 5AM Venture Management LLC

Relationship likelihood: Strong

Venture Partner Emeritus at 5AM Venture Management LLC

Relationship likelihood: Strong

Co-Founder, President & Chief Executive Officer at Expansion Therapeutics, Inc.

Relationship likelihood: Strong

President Emeritus at The Scripps Research Institute

Relationship likelihood: Strong

President & Chief Executive Officer at Wildcat Discovery Technologies, Inc.

Relationship likelihood: Strong

President & Vice President at Alta Partners III, Inc.

Relationship likelihood: Strong

Paths to John Diekman
Potential Connections via
Relationship Science
You
John Diekman
Founding Partner at 5AM Venture Management LLC
Family Members
Spouse
Former Cultural Program Director at Pacific Telesis Foundation

Education
Ph.D. in Chemistry

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

B.A. in Chemistry

Princeton University is a vibrant community of scholarship and learning that stands in the nation's service and in the service of all nations. Chartered in 1746, Princeton is the fourth-oldest college in the United States. Princeton is an independent, coeducational, nondenominational institution that provides undergraduate and graduate instruction in the humanities, social sciences, natural sciences and engineering. As a world-renowned research university, Princeton seeks to achieve the highest levels of distinction in the discovery and transmission of knowledge and understanding. At the same time, Princeton is distinctive among research universities in its commitment to undergraduate teaching. Today, more than 1,100 faculty members instruct approximately 5,000 undergraduate students and 2,500 graduate students. The University's generous financial aid program ensures that talented students from all economic backgrounds can afford a Princeton education.

Honorary Doctor of Laws

Monash University (or simply Monash) is a public university based in Melbourne, Australia. It was founded in 1958 and is the second oldest university in the State of Victoria. Monash is a member of Australia's Group of Eight and the ASAIHL, and is the only Australian member of the influential M8 Alliance of Academic Health Centers, Universities and National Academies. Monash enrolls approximately 45,000 undergraduate and 17,000 graduate students,[2] making it the university with the largest student body in Australia. It also has more applicants than any university in the state of Victoria.[3] Monash is home to major research facilities, including the Australian Synchrotron, the Monash Science Technology Research and Innovation Precinct (STRIP), the Australian Stem Cell Centre, 100 research centres[4] and 17 co-operative research centres. In 2011, its total revenue was over $1.5 billion, with external research income around $282 million.[5] The university has eight campuses, six of which are in Victoria (Clayton, Caulfield, Berwick, Peninsula, Parkville, and Gippsland), one in Malaysia, and one in South Africa.[6] Monash also has a research and teaching centre in Prato, Italy,[7] a graduate research school in Mumbai, India[8] and a graduate school in Jiangsu Province, China.[9] Since December 2011, Monash has also had a global alliance with the University of Warwick in the United Kingdom.[10] The Clayton campus contains the Robert Blackwood Hall, named after the university's founding Chancellor Sir Robert Blackwood and designed by Sir Roy Grounds, which boasts superb acoustics and is considered Melbourne's best music venue outside the CBD

Career History
Founding Partner
2002 - Current

5AM Ventures focuses on building next-generation life science companies capable of delivering outstanding returns to their investors. the firm support companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science. their portfolio companies spearhead novel approaches to diagnose, prevent and treat a wide range of medical conditions. the firm employs a time-tested, hands-on approach to company-building and, in addition to being an early investor, they often involve in setting company strategy, management recruiting, business development and fundraising. they contribute as board members and frequently take on short-term operating rolese

Founder
1997 - Prior

Bay City Capital invests in both private and public life sciences companies located in the US. The firm targets companies operating in the fields of biopharmaceuticals, drug discovery, medical devices and diagnostics. They acts as lead/co-lead investor and provides financing for seed, early and later stage capital requirements. They takes a seat on the board of directors and makes co-investments.

Chief Executive Officer
1995 - 1997

Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA.

Boards & Committees
Chairman, Board of Directors
2002 - 2010

Phenomix Corp. is a biopharmaceutical company focused on the discovery, development and commercialization of novel small-molecule product candidates directed toward clinically validated targets in significant therapeutic markets. It's internally discovered product candidates are designed to have improved efficacy, safety or convenience relative to existing therapies and other product candidates in clinical development. Its lead product candidate, dutogliptin tartrate, is a dipeptidyl peptidase-4, or DPP-4, inhibitor that it is developing as an oral, once-daily treatment for Type 2 diabetes. Its Phase 2b clinical trial of dutogliptin demonstrated statistically significant reductions in HbA1c when administered in combination with existing drugs for the treatment of Type 2 diabetes. The company commenced its Phase 3 clinical program in the third quarter of 2008. Its second product candidate, PHX1766, is a protease inhibitor currently in Phase 1 of clinical development for the treatment of hepatitis C virus, or HCV, infection.The company intends to maximize the value of its product candidates through independent development, licensing and other partnership opportunities. These may include co-development or co-marketing agreements, licensing agreements with pharmaceutical and biotechnology companies that possess established development and commercialization capabilities or direct commercialization by building its own sales and marketing force.

Vice Chairman, Board of Directors
Prior

Bio*One Capital focuses on companies located in Singapore, Asia, Europe and the US. The firm mainly targets the companies operating in the fields of biotechnology, pharmaceuticals, and medical technology companies and start-ups to facilitate the growth of a vibrant biomedical sciences sectors. The firm provides seed & early stage capital requirements.

Director
Prior

Marcadia Biotech, Inc. develops therapeutic products for diabetes and obesity. It is a biopharmaceutical company focuses on developing a broad portfolio of drug candidates for treatment of diabetes and obesity. The company was founded in 2005 and is headquartered in Carmel, IN.

Trustee
Prior

California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA.

Director
Prior

TO INSPIRE THE INNOVATOR IN EVERYONE.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$10K - $25K
2019

TO INSPIRE THE INNOVATOR IN EVERYONE.

$50K +
2018

Humane Society of Silicon Valley is an an independent 501(c)(3) non-profit organization located in Milpitas, CA, that has been serving people and pets for over 80 years.

$25K +
2018

The mission of the Djerassi Resident Artists Program is to support and enhance the creativity of artists by providing uninterrupted time for work, reflection, and collegial interaction in a setting of great natural beauty, and to preserve the land on which the Program is situated.

Political Donations
$1,000
2012

Former President of United States

$1,000
2012

Former Governor of Nebraska

$2,500
2012

Senator at Office of the Senator from Utah, Mitt Romney

Transactions
Details Hidden

Smith & Nephew Plc purchases Ceterix Orthopaedics, Inc. from Versant Venture Management LLC, 5AM Venture Management LLC, Novo Ventures 1 A/S

Details Hidden

5AM Co-Investors IV LP raised money in a private placement transaction

Details Hidden

5AM Ventures IV LP raised money in a private placement transaction

Awards & Honors
Monash University
Order of Australia
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by John Diekman. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of John Diekman's profile does not indicate a business or promotional relationship of any kind between RelSci and John Diekman.